Yunfei Lv

No. 79, Qingchun Road
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.

Journal: Annals of hematology

Published: December 02, 2025

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China.

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China.

Journal: Annals of hematology

Published: October 27, 2025

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.

Journal: Annals of hematology

Published: October 07, 2025

Revealing tumor microenvironmental heterogeneity and prognostic value in angioimmunoblastic T-cell lymphoma via spatial transcriptome sequencing.

Revealing tumor microenvironmental heterogeneity and prognostic value in angioimmunoblastic T-cell lymphoma via spatial transcriptome sequencing.

Journal: Cell death & disease

Published: January 16, 2025

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report.

Journal: Annals of hematology

Published: August 13, 2023

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.

Journal: Therapeutic advances in hematology

Published: July 15, 2023

Rituximab-bortezomib-dexamethasone induce high response rates in iMCD in clinical practice.

Rituximab-bortezomib-dexamethasone induce high response rates in iMCD in clinical practice.

Journal: British journal of haematology

Published: May 09, 2023

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: January 21, 2023

The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia.

The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia.

Journal: Journal of hematology & oncology

Published: September 03, 2020

Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.

Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 17, 2020

Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.

Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.

Journal: Molecular oncology

Published: December 30, 2019

miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia.

miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia.

Journal: Frontiers in bioengineering and biotechnology

Published: December 20, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026